Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer

Cancer Lett. 2016 May 28;375(1):114-126. doi: 10.1016/j.canlet.2016.02.058. Epub 2016 Mar 7.

Abstract

Piperlongumine (PL), a natural alkaloid isolated from the fruit of long pepper, is known to selectively kill tumor cells while sparing their normal counterparts. However, the cellular target and potent anticancer efficacy of PL in numerous types of human cancer cells have not been fully defined. We report here that PL may interact with the thioredoxin reductase 1 (TrxR1), an important selenocysteine (Sec)-containing antioxidant enzyme, to induce reactive oxygen species (ROS)-mediated apoptosis in human gastric cancer cells. By inhibiting TrxR1 activity and increasing intracellular ROS levels, PL induces a lethal endoplasmic reticulum stress and mitochondrial dysfunction in human gastric cancer cells. Importantly, knockdown of TrxR1 sensitizes cells to PL treatment, and PL displays synergistic lethality with GSH inhibitors (BSO and Erastin) against gastric cancer cells. In vivo, PL treatment markedly reduces the TrxR1 activity and tumor cell burden. Remarkably, TrxR1 was significantly overexpressed in gastric cancer cell lines and human gastric cancer tissues. Targeting TrxR1 with PL thus discloses a previously unrecognized mechanism underlying the biological activity of PL and provides an in-depth insight into the action of PL in the treatment of gastric cancer.

Keywords: ER stress; Mitochondrial dysfunction; Piperlongumine; Reactive oxygen species; Thioredoxin reductase 1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Cell Line, Tumor
  • Dioxolanes / pharmacology*
  • Endoplasmic Reticulum Stress
  • Female
  • Humans
  • Membrane Potential, Mitochondrial
  • Mice, Inbred BALB C
  • Mice, Nude
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Reactive Oxygen Species / metabolism
  • Stomach Neoplasms / drug therapy*
  • Stomach Neoplasms / pathology
  • Thioredoxin Reductase 1 / antagonists & inhibitors*
  • Tumor Burden
  • Xenograft Model Antitumor Assays

Substances

  • Antineoplastic Agents
  • BCL2 protein, human
  • Dioxolanes
  • Proto-Oncogene Proteins c-bcl-2
  • Reactive Oxygen Species
  • TXNRD1 protein, human
  • Thioredoxin Reductase 1
  • piperlongumine